HIV Treatment, Alcohol, and Ethnicity

As dyslipidemia has been reported in 40% to 80% of patients treated with highly active antiretroviral therapy (HAART) for HIV, it would be helpful to identify risk factors for HAART-related dyslipidemia. Such knowledge could enable clinicians to tailor their HAART regimens appropriately and take preventive action against cardiovascular disease in at-risk patients.